Literature DB >> 26702742

Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income Country: A Nation-wide Study from Iran.

Masoud M Malekzadeh1, Homayoon Vahedi1, Kimiya Gohari2, Parinaz Mehdipour3, Sadaf G Sepanlou1, Nasser Ebrahimi Daryani4, Mohammad-Reza Zali5, Fariborz Mansour-Ghanaei6, Alireza Safaripour7, Rahim Aghazadeh5, Hassan Vossoughinia8, Hafez Fakheri9, Mohammad H Somi10, Iradj Maleki9, Vahid Hoseini9, Mohammad-Reza Ghadir11, Hamed Daghaghzadeh12, Payman Adibi12, Hamid Tavakoli12, Alireza Taghavi7, Mohammad-Javad Zahedi13, Taghi Amiriani14, Masoud Tabib15, Zainab Alipour15, Hossein Nobakht16, Abbas Yazdanbod17, Masoud Sadreddini18, Alireza Bakhshipour19, Ahmad Khosravi8, Pejman Khosravi20, Siavosh Nasseri-Moghaddam1, Shahin Merat1, Rasoul Sotoudehmanesh1, Farhad Barazandeh21, Peyman Arab22, Nadieh Baniasadi23, Seyyed-Javad Pournaghi20, Mahboubeh Parsaeian24, Farshad Farzadfar3, Reza Malekzadeh25.   

Abstract

BACKGROUND: The burden of inflammatory bowel disease (IBD) hasn't been reported in Iran. We aimed to estimate the prevalence and incidence of IBD and its trend in Iran at national and subnational level from 1990 to 2012.
METHODS: We conducted a systematic review of English and Persian databases about the epidemiology of IBD. We also collected outpatient data from 17 provinces of Iran using almost all public and private referral gastroenterology clinics. Prevalence and incidence rate was calculated at national and subnational levels. The Kriging method was used to extrapolate provinces with missing data and GPR model to calculate time trends of rates at subnational level.
RESULTS: We found 16 case series, two population-based studies, and two review articles. We collected 11,000 IBD cases from outpatient databases. Among them, 9,269 (84.26%) had ulcerative colitis (UC), 1,646 (14.96%) had Crohn's disease (CD), and 85 had intermediate colitis (IC). A total of 5,452 (49.56%) patients were male. Mean age at diagnosis was 32.80 years (CI: 13 - 61) for UC and 29.98 years (CI: 11 - 58) for CD. Annual incidences of IBD, UC, and CD in 2012 were 3.11, 2.70, and 0.41 per 100,000 subjects respectively. Prevalence of IBD, UC, and CD in 2012 were 40.67, 35.52, and 5.03 per 100,000 subjects respectively. The incidence of UC and CD showed a significant increase during the study period (P for trend < 0.05).
CONCLUSIONS: The incidence and prevalence of IBD are increasing in Iran. Establishing a national IBD registry seems necessary for comprehensive care of IBD patients in Iran.

Entities:  

Mesh:

Year:  2016        PMID: 26702742     DOI: 0161901/AIM.003

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  28 in total

Review 1.  Inflammation: a highly conserved, Janus-like phenomenon-a gastroenterologist' perspective.

Authors:  Davide Giuseppe Ribaldone; Rinaldo Pellicano; Giovanni Clemente Actis
Journal:  J Mol Med (Berl)       Date:  2018-07-09       Impact factor: 4.599

2.  Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.

Authors:  Daniela Simian; Daniela Fluxá; Lilian Flores; Jaime Lubascher; Patricio Ibáñez; Carolina Figueroa; Udo Kronberg; Raúl Acuña; Mauricio Moreno; Rodrigo Quera
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

3.  Oral manifestations in inflammatory bowel disease: A cross-sectional study in Isfahan.

Authors:  Faezeh Khozeimeh; Hadi Shakerin; Hamed Daghaghzadeh; Fereshteh Najarzadegan; Zahra Golestannejad; Peyman Adibi
Journal:  Dent Res J (Isfahan)       Date:  2021-02-23

4.  A population based case-control study of association between dietary calcium intake and ulcerative colitis in adults.

Authors:  Zahra Hajhashemy; Parvane Saneei; Ammar Hassanzadeh Keshteli; Hamed Daghaghzadeh; Hamid Tavakkoli; Peyman Adibi; Ahmad Esmaillzadeh
Journal:  Sci Rep       Date:  2022-05-12       Impact factor: 4.996

Review 5.  Ophthalmic manifestations in patients with inflammatory bowel disease: A review.

Authors:  Leandro Lopes Troncoso; Ana Luiza Biancardi; Haroldo Vieira de Moraes; Cyrla Zaltman
Journal:  World J Gastroenterol       Date:  2017-08-28       Impact factor: 5.742

6.  Current Challenges of Liver Transplantation in Iran.

Authors:  Reza F Saidi; Seyed Mohammad Kazemaini; Reza Malekzadeh
Journal:  Middle East J Dig Dis       Date:  2018-01-11

7.  Protective Effect of Asacol in Combination with Pantoprazole in Ulcerative Colitis Patients Who Defecate Asacol Tablets Intactly: A Clinical Trial Study.

Authors:  Homayoon Bashiri; Arezoo Bozorgomid
Journal:  Clin Exp Gastroenterol       Date:  2020-01-24

8.  National and Subnational Cancer Incidence for 22 Cancer Groups, 2000 to 2016: A Study Based on Cancer Registration Data of Iran.

Authors:  Javad Khanali; Ali-Asghar Kolahi
Journal:  J Cancer Epidemiol       Date:  2021-07-12

9.  A randomized controlled trial on the coloprotective effect of coenzyme Q10 on immune-inflammatory cytokines, oxidative status, antimicrobial peptides, and microRNA-146a expression in patients with mild-to-moderate ulcerative colitis.

Authors:  Farnaz Farsi; Nasser Ebrahimi-Daryani; Fereshteh Golab; Abolfazl Akbari; Leila Janani; Mohammad Yahya Karimi; Pardis Irandoost; Naimeh Mesri Alamdari; Shahram Agah; Mohammadreza Vafa
Journal:  Eur J Nutr       Date:  2021-02-23       Impact factor: 4.865

10.  Epidemiologic Characteristics of Patients with Inflammatory Bowel Disease in Kermanshah, Iran.

Authors:  Mehdi Zobeiri; Homayoon Bashiri; Lotfollah Askari; Ali Asghar Keshavars; Ramin Tavvafzadeh; Kiomars Fatahi; Farid Najafi
Journal:  Middle East J Dig Dis       Date:  2017-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.